The Lupus Market region analysis reveals substantial geographic heterogeneity in disease burden, healthcare capacity, regulatory environments, and treatment accessibility that collectively shape market development trajectories across continents. North America maintains market leadership driven by advanced healthcare infrastructure, robust pharmaceutical research presence,...